Today's News | Note: News feeds may no longer be available for the articles on this page.

Roche Releases Actemra Data On Rheumatoid Arthritis 4:56 AM 5/25/2009
Wall Street Journal - USA
Roche Holding AG said two-year data from the LITHE study demonstrate that Actemra (tocilizumab; Roactemra in the EU) continues to be highly effective at inhibiting joint structural damage with consistently high remission rates. ...

Shionogi Preparing to Submit Flu Drug for Government Approval 8:07 PM 5/24/2009
Bloomberg - USA
Osaka-based Shionogi & Co is currently analyzing phase 3 test data for the drug Peramivir. ...

Pfizer looking at biotech firm Intercytex - paper 1:54 PM 5/24/2009
Reuters - USA
Pfizer's interest is based on Intercytex's work age-related macular degeneration which causes blindness. ...

SkyePharma lung drug accepted for FDA review 4:11 AM 5/22/2009
Reuters - USA
SkyePharma moved a step closer to getting its new asthma drug Flutiform approved in the US with the Food and Drug Administration accepting their application for review. ...

J&J to buy Cougar Biotech for $1 billion cash 5:01 PM 5/21/2009
The Associated Press
Johnson & Johnson will buy Cougar Biotechnology to add drugs in development for the treatment of prostate cancer, breast cancer, and the plasma-cell cancer multiple myeloma. ...

Acting US FDA chief defends rise in industry fees 4:15 PM 5/21/2009
Reuters - USA
The acting head of the US FDA defended the request for more funding and an increase in fees from the very industries the agency regulates. ...

Jury Still Out On Isis Cholesterol Drug 1:57 PM 5/21/2009
Forbes - NY,USA
Isis Pharmeceuticals and partner Genzyme released lackluster data on their cholesterol treatment mipomersen. Cardiologists say not to write off the drug just yet. ...

Novartis eyes blockbuster sales for new lung drug 8:46 AM 5/21/2009
Reuters - USA
Novartis' experiment QAB149 drug significantly improved lung function when compared with two established respiratory drugs in late stage clinicals. ...

HGSI asks for FDA approval of anthrax drug ABthrax 7:06 AM 5/21/2009
Forbes - NY,USA
Human Genome Sciences Inc submitted a Biologics License Application for ABthrax (raxibacumab) for US FDA approval to treat inhaled anthrax. ...

J&J Would End Schering Drug Rights 4:39 AM 5/21/2009
Wall Street Journal - USA
Johnson & Johnson's Centocor unit will try to regain full marketing rights to arthritis treatment Remicade now that partner Schering-Plough is being acquired by Merck & Co. ...

AstraZeneca wins US ban on generic of asthma drug 4:26 PM 5/20/2009
Reuters - USA
A US court has granted an injunction that bars Apotex from selling a generic of AstraZeneca's Pulmicort Respules asthma medicine prior to a patent infringement trial. ...

Pfizer Reaches Deal to Market Generic Drugs 7:51 AM 5/20/2009
Wall Street Journal - USA
Pfizer Inc reached deals with Aurobindo Pharma Ltd to sell 60 generic drugs and Claris Lifesciences Ltd to market 15 generic injectables. ...

Cataract Surgery Complications Are Linked to a Urinary Drug 7:00 AM 5/20/2009
New York Times - United States
Flomax (tamsulosin) relieves urinary problems by relaxing smooth muscle in prostate and bladder. A similar effect on smooth muscle in the iris complicates cataract surgery by causing floppy iris syndrome. ...

AstraZeneca Planned Off-Label Drug Sales in 2000, Documents Say 3:50 AM 5/20/2009
Bloomberg - USA
More than 15,000 patients have sued AstraZeneca claiming the company withheld information on a connection between diabetes and Seroquel with a strategy of marketing the antipsychotic drug for unapproved uses. ...

US FDA panel rejects Debiovision, Salix drug 2:53 PM 5/19/2009
Reuters - USA
A US FDA advisory panel voted 14-0 that current data did not show that the benefits of Debiovision Inc's drug Sanvar outweighed potential risks treating a dangerous type of bleeding in the esophagus. ...

<- Day Earlier | Today's News